Codexis and Molecular Assemblies Partner to Transform the Field of DNA Synthesis

On June 23, 2020, Codexis and Molecular Assemblies announced a partnership to engineer enzymes to accelerate the commercialization of enzymatic DNA synthesis. SynBioBeta founder John Cumbers talked with John Nicols and Mike Kamdar, the CEOs of Codexis and Molecular Assemblies, respectively, about the significance of enzymatic DNA synthesis and what this partnership means to synthetic biology and the entire biotechnology sector
https://www.forbes.com/sites/johncumbers/2020/06/23/a-new-way-of-making-dna-is-about-to-revolutionize-the-biotech-industry/

The synthesis of DNA is a crucial component in several industries including pharmaceuticals, agriculture, and synthetic biology. The current chemical process for gene and DNA synthesis was developed in the 1980s and has long been recognized as a bottleneck to expanding the applications for synthetic DNA. Enzymatic DNA synthesis can overcome the limitations of chemical synthesis and enable ever-lengthening strands of DNA, with the ultimate goal of creating a complete genome. This promises to impact current applications for synthetic DNA such as biotherapeutics, diagnostics, and production of improved textiles, crops, biomaterials and polymers. It also promises to open up new applications, including bio-computing and DNA-based data storage.

Sign up to receive news about upcoming events, and the latest news in synthetic biology: https://synbiobeta.com/subscribe/

Join the conversation on:
Twitter: https://twitter.com/synbiobeta
Facebook: https://www.facebook.com/synbiobeta
LinkedIn: https://www.linkedin.com/company/synbiobeta
Instagram: https://www.instagram.com/synbiobeta/

Видео Codexis and Molecular Assemblies Partner to Transform the Field of DNA Synthesis канала Built With Biology